Phibro Animal Health Corporation (USD) Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

Phibro Animal Health Corporation (USD) Active

Glenpointe Centre East, Teaneck, NJ, US, 07666-6712

Stock Price USD

Price Change

Last Dividend USD

C+

Latest Rating

PAHC's stock peer is ANIP (ANI Pharmaceuticals, Inc.)

PAHC's stock peer is BHHKF (Craftport Cannabis Corp.)

PAHC's stock peer is COLL (Collegium Pharmaceutical, Inc.)

PAHC's stock peer is CVGRF (City View Green Holdings Inc.)

PAHC's stock peer is DCPH (Deciphera Pharmaceuticals, Inc.)

PAHC's stock peer is DLTNF (Delta 9 Cannabis Inc.)

PAHC's stock peer is EGRX (Eagle Pharmaceuticals, Inc.)

PAHC's stock peer is PBH (Prestige Consumer Healthcare Inc.)

PAHC's stock peer is PCRX (Pacira BioSciences, Inc.)

PAHC's stock peer is PROC (Procaps Group S.A.)

PAHC's stock peer is RAMMF (RAMM Pharma Corp.)

PAHC's stock peer is RDY (Dr. Reddy's Laboratories Limited)

PAHC's stock peer is SHPHF (Sihuan Pharmaceutical Holdings Group Ltd.)

PAHC's stock peer is SPBBF (Speakeasy Cannabis Club Ltd.)

PAHC's stock peer is SSIC (Silver Spike Investment Corp.)

Healthcare Drug Manufacturers - Specialty & Generic

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

20%

Dcf Rating

80%

Return On Equity

80%

Return On Assets

20%

Debt To Equity

20%

Price To Earnings

40%

Price To Book

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
2025-06-04	2025-06-25	0.12	1.97 %	Quarterly
2025-03-05	2025-03-26	0.12	2.04 %	Quarterly
2024-11-27	2024-12-18	0.12	2.03 %	Quarterly
2024-11-25	2024-12-18	0.12	1.99 %	Quarterly
2024-09-04	2024-09-25	0.12	2.44 %	Quarterly
2024-06-05	2024-06-26	0.12	2.77 %	Quarterly
2024-03-06	2024-03-27	0.12	3.63 %	Quarterly
2023-11-29	2023-12-20	0.12	4.95 %	Quarterly
2023-09-06	2023-09-27	0.12	3.57 %	Quarterly
2023-06-07	2023-06-28	0.12	3.53 %	Quarterly
2023-03-01	2023-03-22	0.12	3.06 %	Quarterly
2022-11-30	2022-12-21	0.12	3.98 %	Quarterly
2022-09-07	2022-09-28	0.12	3.27 %	Quarterly
2022-06-01	2022-06-22	0.12	2.50 %	Quarterly
2022-03-02	2022-03-23	0.12	2.31 %	Quarterly
2021-11-24	2021-12-15	0.12	2.20 %	Quarterly
2021-09-01	2021-09-22	0.12	1.98 %	Quarterly
2021-06-02	2021-06-23	0.12	1.71 %	Quarterly
2021-03-03	2021-03-24	0.12	2.17 %	Quarterly
2020-11-25	2020-12-16	0.12	2.45 %	Quarterly
2020-09-02	2020-09-23	0.12	2.33 %	Quarterly
2020-06-03	2020-06-24	0.12	1.87 %	Quarterly
2020-03-04	2020-03-25	0.12	1.88 %	Quarterly
2019-11-27	2019-12-18	0.12	1.97 %	Quarterly
2019-09-04	2019-09-25	0.12	2.35 %	Quarterly
2019-06-05	2019-06-26	0.12	1.54 %	Quarterly
2019-03-06	2019-03-27	0.12	1.51 %	Quarterly
2018-11-28	2018-12-19	0.12	1.29 %	Quarterly
2018-09-05	2018-09-26	0.10	0.84 %	Quarterly
2018-06-06	2018-06-27	0.10	0.87 %	Quarterly
2018-03-07	2018-03-28	0.10	1.03 %	Quarterly
2017-12-06	2017-12-27	0.10	1.20 %	Quarterly
2017-09-06	2017-09-27	0.10	1.10 %	Quarterly
2017-05-31	2017-06-22	0.10	1.16 %	Quarterly
2017-03-01	2017-03-22	0.10	1.41 %	Quarterly
2016-11-30	2016-12-21	0.10	1.42 %	Quarterly
2016-09-07	2016-09-28	0.10	1.55 %	Quarterly
2016-06-01	2016-06-22	0.10	2.07 %	Quarterly
2016-03-02	2016-03-23	0.10	1.45 %	Quarterly
2015-12-02	2015-12-23	0.10	1.23 %	Quarterly
2015-09-02	2015-09-23	0.10	1.13 %	Quarterly
2015-06-03	2015-06-24	0.10	0.86 %	Quarterly
2015-03-04	2015-03-25	0.10	0.54 %	Quarterly
2014-12-03	2014-12-23	0.10	0.33 %	Quarterly
2014-09-03	2014-09-24	0.10	0.52 %	Quarterly

Recent News

Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference. Chief Operating Officer, Larry Miller along with Director and Executive Vice President, Corporate Strategy, Daniel Bendheim will address financial analysts and investors on Thursday, May 29, 2025, at 8:35 AM ET at the Lotte New York Hotel in New York. The live audio presentation will be available on the Phibro Animal Health Corporation Inv.

2025-05-22 16:00:00

Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2025, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended March 31, 2025 (compared to the three months ended March 31, 2024) Net sales of $347.8 million, an increase of $84.6 million, or 32% Net income of $20.9 million, an increase of $12.5 million Diluted earnin.

2025-05-07 16:30:00

Phibro Animal Health Corporation Declares Quarterly Dividend

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 25, 2025, to stockholders of record at the close of business on June 4, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with lives.

2025-05-06 16:15:00

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 7, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 8, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-202.

2025-04-23 16:00:00

Phibro Animal Health Corporation to Participate at Barclays Annual Global Healthcare Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Barclays Annual Global Healthcare Conference. Chief Financial Officer, Glenn David will address financial analysts and investors on Thursday, March 13, 2025, at 9:00 AM ET at the Loews Miami Beach Hotel. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com. A replay of the session will.

2025-03-05 16:00:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions